It also appears from the report, that the Patents that GID use run out in 2017 !!!
Where does that leave them?
so was the rise in sp a pump and dump? or is there something else going on?
If anyone can clear the air and tell us, please do
As I said in an earlier post, the cost of chasing the FDA and trying to get
It going in the States was a massive mistake, at one stage they leased
a building over there of 33,000sq m. !!!!!! too many execs and boffins
And not enough sales and promotion. American hubris at work.
Jeez, selling a drug free solution to the obese and diabetics, should have been easy, but
You have to keep costs under control.....'market out of town'....Build a roaring success
and then hit the big time.(USA)
I have over 35 years in marketing.......these are basic principals.....
GID Price at posting:
4.3¢ Sentiment: Buy Disclosure: Not Held
